M. R. Green

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2004 · 367 citations

Randomized Clinical Trial, Surgical Oncology, Iii Nsclc +14

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

Gary M. Strauss, Justine Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2004 · 107 citations

Randomized Clinical Trial, Surgical Oncology, Iii Nsclc +14

Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial

Everett E. Vokes, James E. Herndon, Michael J. Kelley et al. · Journal of Clinical Oncology · 2004 · 70 citations

Radiation Medicine, Health Sciences, Radiation Therapy +15

CALGB 30306: A phase II study of cisplatin (C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)

Neal Ready, Arkadiusz Z. Dudek, X. F. Wang et al. · Journal of Clinical Oncology · 2007 · 49 citations

Cancer Management, Pathology, Phase Ii Study +16

Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines.

Hamid R. Bahadori, Caio Max S. Rocha Lima, M. R. Green et al. · PubMed · 2000 · 46 citations

Tumor Biology, Synergistic Effect, Oncology +12